The frequency of NOTCH1 variants in T-acute lymphoblastic leukemia/lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma among Jordanian patients

Ann Diagn Pathol. 2019 Apr:39:53-58. doi: 10.1016/j.anndiagpath.2019.01.004. Epub 2019 Jan 24.

Abstract

The transmembrane receptor NOTCH1 is thought to be associated with the development and progression of T-acute lymphoblastic leukemia (T-ALL)/T-lymphoblastic lymphoma (T-LBL) and chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL). The current study aimed to characterize NOTCH1 expression and elucidate the variants in the functional PEST domain of the receptor in T-ALL/LBL and CLL/SLL. The nuclear expression of NOTCH1 protein was detected in 25% and 5% of cases of T-ALL/LBL and CLL/SLL, respectively, whereas cytoplasmic expression was detected in 33.3% and 15% cases, respectively. The frequency of variants in T-ALL/LBL was 33%, whereas 40% of CLL/SLL cases possessed variants. Four novel variants were identified; three of which were non-synonymous and one common variant c.7280_7280delG between T-ALL/LBL and CLL/SLL cases. The previously described variant, c.7541_7542delCT, was detected in 3 cases of CLL/SLL. These results provide support for the contribution of NOTCH1 in the etiology of these types of cancers.

Keywords: Chronic lymphocytic leukemia; Jordan; NOTCH1; PEST domain; T-acute lymphoblastic leukemia.

MeSH terms

  • Cell Nucleus / metabolism
  • Cytoplasm / metabolism
  • Female
  • Genetic Predisposition to Disease
  • Genetic Variation*
  • Humans
  • Jordan
  • Leukemia, Lymphocytic, Chronic, B-Cell / genetics*
  • Male
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / genetics*
  • Protein Domains
  • Receptor, Notch1 / chemistry
  • Receptor, Notch1 / genetics*
  • Receptor, Notch1 / metabolism*

Substances

  • NOTCH1 protein, human
  • Receptor, Notch1